Alex Tchinda, Joubert Olivier, Kouitat-Njiwa Richard, Bravetti Pierre
Université de Lorraine, CNRS, IJL, F-54000 Nancy, France.
J Funct Biomater. 2025 May 22;16(6):191. doi: 10.3390/jfb16060191.
Innovation in oral implantology is constantly on the move, with a constant search for new biomaterials to overcome many of the limitations of the biomaterials used in current implantable medical devices. This study explores the biocompatibility of an innovative 5% calcium-to-zirconia (Ca-SZ) coating deposited by PVD on TA6V substrates for use in oral implantology. In order to determine the contribution of the Ca-SZ coating, an in vitro biocompatibility study was carried out to assess the potential influence of the Ca-SZ coating (1) on the viability and proliferation of saos-2 and HaCaT cells over a short-term exposure period of 96 h, (2) on the synthesis of pro-inflammatory cytokines, and (3) on the synthesis of osteogenic differentiation markers over a long-term exposure period of 21 days, in comparison with reference biomaterials. The sampling consisted of = 3 biological replicates, and a -value of <0.05 was used as the threshold for statistical significance. Viability and proliferation kinetics to WST-1 and CyQUANT NF, respectively, showed improved viability/proliferation of Ca-SZ exposed to both cell lines independently. The TNF-alpha and IL-6 assays revealed reduced levels of cytokines compared with the reference biomaterials, including the control groups. In parallel, in Saos-2 cells exposed to Ca-SZ for 21 days under osteogenic conditions increased expression of osteogenic markers, such as the synthesis of soluble collagens, alkaline phosphatase (ALP), osteopontin, and osteocalcin, reflecting dynamic and facilitated osteoblastic differentiation, which was supported by the formation of hydroxyapatite (HA) crystals observed by SEM micrograph and confirmed by EDS mapping. In conclusion, Ca-SZ demonstrates an overall better biocompatibility compared with reference biomaterials, linked to a bioactive interaction of calcium, promoting cell proliferation and differentiation for optimal osteointegration, underlining its potential as a relevant innovation for next-generation implants.
口腔种植学领域的创新一直在持续推进,人们不断寻找新型生物材料,以克服当前可植入医疗设备中所用生物材料的诸多局限性。本研究探讨了通过物理气相沉积(PVD)法在TA6V基体上沉积的一种创新性5%钙锆涂层(Ca-SZ)用于口腔种植学的生物相容性。为了确定Ca-SZ涂层的作用,开展了一项体外生物相容性研究,以评估Ca-SZ涂层(1)在96小时短期暴露期内对saos-2和HaCaT细胞活力和增殖的潜在影响,(2)对促炎细胞因子合成的影响,以及(3)在21天长期暴露期内与参考生物材料相比对成骨分化标志物合成的影响。样本包括n = 3个生物学重复,P值<0.05用作统计学显著性阈值。分别针对WST-1和CyQUANT NF的活力和增殖动力学显示,暴露于两种细胞系的Ca-SZ的活力/增殖均得到改善。与参考生物材料(包括对照组)相比,TNF-α和IL-6检测显示细胞因子水平降低。同时,在成骨条件下暴露于Ca-SZ 21天的Saos-2细胞中,成骨标志物的表达增加,如可溶性胶原蛋白、碱性磷酸酶(ALP)、骨桥蛋白和骨钙素的合成,反映了动态且促进的成骨细胞分化,扫描电子显微镜(SEM)显微照片观察到的羟基磷灰石(HA)晶体形成以及能谱分析(EDS)图谱证实了这一点。总之,与参考生物材料相比,Ca-SZ表现出总体更好的生物相容性,这与钙的生物活性相互作用有关,促进细胞增殖和分化以实现最佳骨整合,突显了其作为下一代植入物相关创新的潜力。